Karyopharm Therapeutics Inc (KPTI)

09:27 AM

Karyopharm Therapeutics (NASDAQ:KPTI) Issues Quarterly Earnings Results - MarketBeat

09:27 AM

08:24 AM

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2025 Earnings Call Transcript - Insider Monkey

08:24 AM

08:17 AM

RBC Cuts Price Target on Karyopharm Therapeutics to $19 From $30, Keeps Outperform Rating - MarketScreener

08:17 AM

06:40 AM

Quantitative breakdown of Karyopharm Therapeutics Inc. recent moveQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com

06:40 AM

05:29 AM

How Karyopharm Therapeutics Inc. stock compares to industry benchmarksWeekly Trend Summary & Weekly High Return Stock Opportunities - newser.com

05:29 AM

05:16 AM

Karyopharm Therapeutics: Q3 Earnings Snapshot - New Haven Register

05:16 AM

12:21 PM

Karyopharm Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat

12:21 PM

Nov 03, 2025

Karyopharm Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 03, 2025

Nov 03, 2025

What makes Karyopharm Therapeutics Inc. (25K0) stock appealing to growth investors2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Down 36.3% in October - MarketBeat

Nov 03, 2025

Nov 03, 2025

Karyopharm Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Nov 03, 2025

Nov 03, 2025

Karyopharm (Nasdaq: KPTI) grants 800 RSUs to new hire, vesting over 3 years - Stock Titan

Nov 03, 2025

Nov 03, 2025

Karyopharm (KPTI) Reports Strong Q3 2025, Highlights Myelofibros - GuruFocus

Nov 03, 2025

Nov 03, 2025

Karyopharm Therapeutics Inc. Reaffirms Earnings Guidance for the Full Year 2025 - MarketScreener

Nov 03, 2025

Nov 03, 2025

Transcript : Karyopharm Therapeutics Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

Nov 03, 2025

Nov 03, 2025

Karyopharm Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Nov 03, 2025

Nov 03, 2025

Earnings call transcript: Karyopharm Q3 2025 shows revenue growth, pre-market dip - Investing.com

Nov 03, 2025

Nov 03, 2025

How geopolitical tensions affect Karyopharm Therapeutics Inc. stock2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Karyopharm Grows Revenue With Strong XPOVIO Sales And Partnerships - Finimize

Nov 03, 2025

Nov 03, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock a top hedge fund pickIPO Watch & Safe Capital Growth Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Analyzing net buyer seller activity in Karyopharm Therapeutics Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Karyopharm (KPTI) Surpasses Q3 Revenue Expectations with Clinica - GuruFocus

Nov 03, 2025

Nov 03, 2025

Karyopharm (KPTI) Projects Revenue Growth and Expense Reduction for FY25 - GuruFocus

Nov 03, 2025

Nov 03, 2025

Is Karyopharm Therapeutics Inc. stock safe for conservative investorsQuarterly Trade Summary & Verified Short-Term Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView

Nov 03, 2025

Nov 03, 2025

Karyopharm Therapeutics' Q3 net loss widens - TradingView

Nov 03, 2025

Nov 03, 2025

Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress - PR Newswire

Nov 03, 2025

Nov 03, 2025

Will Karyopharm Therapeutics Inc. stock gain from strong economyQuarterly Portfolio Summary & Community Consensus Trade Signals - newser.com

Nov 03, 2025

Nov 03, 2025

How Karyopharm Therapeutics Inc. (25K0) stock reacts to new regulationsQuarterly Market Review & Verified Technical Trade Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Karyopharm Therapeutics Inc. stock trend outlook and recovery path2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Is it time to cut losses on Karyopharm Therapeutics Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com

Nov 03, 2025

Nov 03, 2025

Using Ichimoku Cloud for Karyopharm Therapeutics Inc. technicalsPortfolio Risk Summary & Low Drawdown Trading Techniques - newser.com

Nov 03, 2025

Nov 02, 2025

Will Karyopharm Therapeutics Inc. outperform the marketM&A Rumor & Safe Entry Trade Reports - newser.com

Nov 02, 2025

Nov 02, 2025

Technical signs of recovery in Karyopharm Therapeutics Inc.July 2025 Technicals & Verified Momentum Stock Watchlist - newser.com

Nov 02, 2025

Nov 02, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock cheap vs fundamentalsMarket Performance Summary & Fast Entry High Yield Stock Tips - newser.com

Nov 02, 2025

Nov 02, 2025

Will Karyopharm Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Drop Watch & Growth Focused Stock Reports - newser.com

Nov 02, 2025

Nov 02, 2025

Can Karyopharm Therapeutics Inc. stock continue upward trendChart Signals & Fast Exit and Entry Trade Guides - newser.com

Nov 02, 2025

Nov 01, 2025

Is Karyopharm Therapeutics Inc. stock vulnerable to regulatory risksWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Karyopharm Therapeutics Inc expected to post a loss of $3.13 a shareEarnings Preview - TradingView

Oct 31, 2025

Oct 31, 2025

Earnings To Watch: Karyopharm Therapeutics Inc (KPTI) Reports Q3 2025 Result - Yahoo Finance

Oct 31, 2025